Terms: = Prostate cancer AND AKAP9, AKAP350, 10142, ENSG00000127914, KIAA0803, Q99996, AKAP450, YOTIAO, PRKA9, HYPERION, MU-RMS-40_16A, CG-NAP
17 results:
1. Computational Design, Synthesis, and Bioevaluation of 2-(Pyrimidin-4-yl)oxazole-4-carboxamide Derivatives: Dual Inhibition of EGFR
Raghunath Khedkar N; Sindkhedkar M; Joseph A
Bioorg Chem; 2024 Feb; 143():107027. PubMed ID: 38096682
[TBL] [Abstract] [Full Text] [Related]
2. Reducing MRI-guided radiotherapy planning and delivery times via efficient leaf sequencing and segment shape optimization algorithms.
Snyder JE; St-Aubin J; Yaddanapudi S; Marshall S; Strand S; Kruger S; Flynn R; Hyer DE
Phys Med Biol; 2022 Feb; 67(5):. PubMed ID: 35130528
[No Abstract] [Full Text] [Related]
3. Synthesis and cytotoxic evaluation of novel hybrid estrane heterocycles as chemotherapeutic anti-cancer agents.
Nada DS; Elkady DS; Elsayed GH; A-H Abdel-Rahman A; Elmegeed GA
Steroids; 2021 May; 169():108813. PubMed ID: 33652007
[TBL] [Abstract] [Full Text] [Related]
4. Evaluation of radioiodinated protein conjugates and their potential metabolites containing lysine-urea-glutamate (LuG), PEG and closo-decaborate(2-) as models for targeting astatine-211 to metastatic prostate cancer.
Li Y; Chyan MK; Hamlin DK; Nguyen H; Vessella R; Wilbur DS
Nucl Med Biol; 2021 Jan; 92():217-227. PubMed ID: 32409263
[TBL] [Abstract] [Full Text] [Related]
5. Integrative molecular characterization of Chinese prostate cancer specimens.
Lv SD; Wang HY; Yu XP; Zhai QL; Wu YB; Wei Q; Huang WH
Asian J Androl; 2020; 22(2):162-168. PubMed ID: 31134918
[TBL] [Abstract] [Full Text] [Related]
6. Tumour heterogeneity in triplet-paired metastatic tumour tissues in metastatic renal cell carcinoma: concordance analysis of target gene sequencing data.
Kim SH; Park WS; Chung J
J Clin Pathol; 2019 Feb; 72(2):152-156. PubMed ID: 30409839
[TBL] [Abstract] [Full Text] [Related]
7. Automatic replanning of VMAT plans for different treatment machines: A template-based approach using constrained optimization.
Künzel LA; Dohm OS; Alber M; Zips D; Thorwarth D
Strahlenther Onkol; 2018 Oct; 194(10):921-928. PubMed ID: 29846751
[TBL] [Abstract] [Full Text] [Related]
8. Synthesis and biological evaluation of histone deacetylase and DNA topoisomerase II-Targeted inhibitors.
Yamashita M; Tahara T; Hayakawa S; Matsumoto H; Wada SI; Tomioka K; Iida A
Bioorg Med Chem; 2018 May; 26(8):1920-1928. PubMed ID: 29519604
[TBL] [Abstract] [Full Text] [Related]
9. Synthesis of novel benzylidene analogues of betulinic acid as potent cytotoxic agents.
Gupta N; Rath SK; Singh J; Qayum A; Singh S; Sangwan PL
Eur J Med Chem; 2017 Jul; 135():517-530. PubMed ID: 28500966
[TBL] [Abstract] [Full Text] [Related]
10. 1-Piperazinylphthalazines as potential VEGFR-2 inhibitors and anticancer agents: Synthesis and in vitro biological evaluation.
Abou-Seri SM; Eldehna WM; Ali MM; Abou El Ella DA
Eur J Med Chem; 2016 Jan; 107():165-79. PubMed ID: 26590508
[TBL] [Abstract] [Full Text] [Related]
11. Activity guided isolation and modification of juglone from Juglans regia as potent cytotoxic agent against lung cancer cell lines.
Zhang XB; Zou CL; Duan YX; Wu F; Li G
BMC Complement Altern Med; 2015 Nov; 15():396. PubMed ID: 26530090
[TBL] [Abstract] [Full Text] [Related]
12. Synthesis, antiproliferative activity and possible mechanism of action of novel 2-acetamidobenzamides bearing the 2-phenoxy functionality.
Raffa D; Maggio B; Plescia F; Cascioferro S; Raimondi MV; Cancemi G; D'Anneo A; Lauricella M; Cusimano MG; Bai R; Hamel E; Daidone G
Bioorg Med Chem; 2015 Oct; 23(19):6305-16. PubMed ID: 26344588
[TBL] [Abstract] [Full Text] [Related]
13. Implementation of spot scanning dose optimization and dose calculation for helium ions in hyperion.
Fuchs H; Alber M; Schreiner T; Georg D
Med Phys; 2015 Sep; 42(9):5157-66. PubMed ID: 26328967
[TBL] [Abstract] [Full Text] [Related]
14. Is there a single spot size and grid for intensity modulated proton therapy? Simulation of head and neck, prostate and mesothelioma cases.
Widesott L; Lomax AJ; Schwarz M
Med Phys; 2012 Mar; 39(3):1298-308. PubMed ID: 22380362
[TBL] [Abstract] [Full Text] [Related]
15. Helical tomotherapy vs. intensity-modulated proton therapy for whole pelvis irradiation in high-risk prostate cancer patients: dosimetric, normal tissue complication probability, and generalized equivalent uniform dose analysis.
Widesott L; Pierelli A; Fiorino C; Lomax AJ; Amichetti M; Cozzarini C; Soukup M; Schneider R; Hug E; Di Muzio N; Calandrino R; Schwarz M
Int J Radiat Oncol Biol Phys; 2011 Aug; 80(5):1589-600. PubMed ID: 21167651
[TBL] [Abstract] [Full Text] [Related]
16. AXIN2 polymorphism and its association with prostate cancer in a Turkish population.
Pinarbasi E; Gunes EG; Pinarbasi H; Donmez G; Silig Y
Med Oncol; 2011 Dec; 28(4):1373-8. PubMed ID: 21069480
[TBL] [Abstract] [Full Text] [Related]
17. [Fluence-modulated radiotherapy with an optimization-integrated sequencer].
Bär W; Alber M; Nüsslin F
Z Med Phys; 2003; 13(1):12-5. PubMed ID: 12723518
[TBL] [Abstract] [Full Text] [Related]
